These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231 [TBL] [Abstract][Full Text] [Related]
9. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C; Ryu J; Park CB Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909 [TBL] [Abstract][Full Text] [Related]
10. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. Okada T; Wakabayashi M; Ikeda K; Matsuzaki K J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434 [TBL] [Abstract][Full Text] [Related]
11. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. Ferreira ST; Vieira MN; De Felice FG IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973 [TBL] [Abstract][Full Text] [Related]
12. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers. Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493 [TBL] [Abstract][Full Text] [Related]
13. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062 [TBL] [Abstract][Full Text] [Related]
15. Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration. Vieira MN; Forny-Germano L; Saraiva LM; Sebollela A; Martinez AM; Houzel JC; De Felice FG; Ferreira ST J Neurochem; 2007 Oct; 103(2):736-48. PubMed ID: 17727639 [TBL] [Abstract][Full Text] [Related]
16. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Rauk A Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836 [TBL] [Abstract][Full Text] [Related]
17. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation. Kranenburg O; Bouma B; Gent YY; Aarsman CJ; Kayed R; Posthuma G; Schiks B; Voest EE; Gebbink MF Mol Cell Neurosci; 2005 Mar; 28(3):496-508. PubMed ID: 15737740 [TBL] [Abstract][Full Text] [Related]
19. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481 [TBL] [Abstract][Full Text] [Related]